GPAT Return On Equity from 2010 to 2024
| GPAT Stock | 10.08 0.01 0.1% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter 0.14335743 | Current Value 0.088 | Quarterly Volatility 0.20854563 |
Check GP Act financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GP Act's main balance sheet or income statement drivers, such as Other Operating Expenses of 17.9 K, Total Operating Expenses of 17.9 K or Depreciation And Amortization of 18 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. GPAT financial statements analysis is a perfect complement when working with GP Act Valuation or Volatility modules.
GPAT |
Latest GP Act's Return On Equity Growth Pattern
Below is the plot of the Return On Equity of GP Act III Acquisition over the last few years. Return on Equity is the amount of GP Act III net income returned as a percentage of GP Act equity. Return on equity measures GP Act profitability by revealing how much profit GP Act III Acquisition generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. GP Act's Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GP Act's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.0 | 10 Years Trend |
|
Return On Equity |
| Timeline |
GPAT Return On Equity Regression Statistics
| Arithmetic Mean | (0.07) | |
| Coefficient Of Variation | (281.35) | |
| Mean Deviation | 0.17 | |
| Median | (0.19) | |
| Standard Deviation | 0.21 | |
| Sample Variance | 0.04 | |
| Range | 0.5566 | |
| R-Value | 0.68 | |
| Mean Square Error | 0.02 | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 0.03 | |
| Total Sum of Squares | 0.61 |
GPAT Return On Equity History
About GP Act Financial Statements
GP Act shareholders use historical fundamental indicators, such as Return On Equity, to determine how well the company is positioned to perform in the future. Although GP Act investors may analyze each financial statement separately, they are all interrelated. The changes in GP Act's assets and liabilities, for example, are also reflected in the revenues and expenses on on GP Act's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Return On Equity | 0.14 | 0.09 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.